Medication adherence to oral anticancer drugs: systematic review

References

• Regnier Denois V, Poirson J, Nourissat A, et al. Adherence with oral chemotherapy: results from a qualitative study of the behaviour and representations of patients and oncologists. Eur J Cancer Care (Engl). 2011;20(4):520–527.
   PubMed Web of Science ®Google Scholar
• Sabate E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
   Google Scholar
• DiMatteo MR, Giordani PJ, Lepper HS, et al. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40(9):794–811.
   PubMed Web of Science ®Google Scholar
• Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. Bmj. 2006;333(7557):15.
   PubMed Web of Science ®Google Scholar
• Darkow T, Henk HJ, Thomas SK, et al. Treatment interruptions and non-adherence with imatinib and associated healthcare costs: a retrospective analysis among managed care patients with chronic myelogenous leukaemia. Pharmacoeconomics. 2007;25(6):481–496.
   PubMed Web of Science ®Google Scholar
• Verbrugghe M, Verhaeghe S, Lauwaert K, et al. Determinants and associated factors influencing medication adherence and persistence to oral anticancer drugs: a systematic review. Cancer Treat Rev. 2013;39(6):610–621.
   PubMed Web of Science ®Google Scholar
• Clifford S, Barber N, Horne R. Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the Necessity-Concerns Framework. J Psychosom Res. 2008;64(1):41–46.
   PubMed Web of Science ®Google Scholar
• Horne R, Chapman SC, Parham R, et al. Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework. PLoS One. 2013;8(12):e80633.
   PubMed Web of Science ®Google Scholar
• Gebbia V, Bellavia M, Banna GL, et al. Treatment monitoring program for implementation of adherence to second-line erlotinib for advanced non-small-cell lung cancer. Clin Lung Cancer. 2013;14(4):390–398.
   PubMed Web of Science ®Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487–497.
   PubMed Web of Science ®Google Scholar
• Wu JR, Moser DK, Chung ML, et al. Objectively measured, but not self-reported, medication adherence independently predicts event-free survival in patients with heart failure. J Card Fail. 2008;14(3):203–210.
   PubMed Web of Science ®Google Scholar
• Velligan DI, Wang M, Diamond P, et al. Relationships among subjective and objective measures of adherence to oral antipsychotic medications. Psychiatr Serv. 2007;58(9):1187–1192.
   PubMed Web of Science ®Google Scholar
• Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348–354.
   PubMed Web of Science ®Google Scholar
• Daniels T, Goodacre L, Sutton C, et al. Accurate assessment of adherence: self-report and clinician report vs electronic monitoring of nebulizers. Chest. 2011;140(2):425–432.
   PubMed Web of Science ®Google Scholar
• Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res. 2000;42(3):241–247.
   PubMed Web of Science ®Google Scholar
• Chisholm MA, Lance CE, Williamson GM, et al. Development and validation of the immunosuppressant therapy adherence instrument (ITAS). Patient Educ Couns. 2005;59(1):13–20.
   PubMed Web of Science ®Google Scholar
• Critical Appraisal Skills Programme (CASP). CASP checklists; 2014. Available from: http://www.casp-uk.net/#!casp-tools-checklists/c18f8
   Google Scholar
• Kekale M, Talvensaari K, Koskenvesa P, et al. Chronic myeloid leukemia patients’ adherence to peroral tyrosine kinase inhibitors compared with adherence as estimated by their physicians. Patient Prefer Adherence. 2014;8:1619–1627.
   PubMed Web of Science ®Google Scholar
• De Almeida MH, Pagnano KB, Vigorito AC, et al. Adherence to tyrosine kinase inhibitor therapy for chronic myeloid leukemia: a Brazilian single-center cohort. Acta Haematol. 2013;130(1):16–22.
   PubMed Web of Science ®Google Scholar
• Efficace F, Baccarani M, Rosti G, et al. Investigating factors associated with adherence behaviour in patients with chronic myeloid leukemia: an observational patient-centered outcome study. Br J Cancer. 2012;107(6):904–909.
   PubMed Web of Science ®Google Scholar
• Jonsson S, Olsson B, Soderberg J, et al. Good adherence to imatinib therapy among patients with chronic myeloid leukemia–a single-center observational study. Ann Hematol. 2012;91(5):679–685.
   PubMed Web of Science ®Google Scholar
• Bhattacharya D, Easthall C, Willoughby KA, et al. Capecitabine non-adherence: exploration of magnitude, nature and contributing factors. J Oncol Pharm Pract. 2012;18(3):333–342.
   PubMedGoogle Scholar
• Sommers RM, Miller K, Berry DL. Feasibility pilot on medication adherence and knowledge in ambulatory patients with gastrointestinal cancer. Oncol Nurs Forum. 2012;39(4):E373–E379.
   PubMedGoogle Scholar
• Noens L, van Lierde MA, De Bock R, et al. Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study. Blood. 2009;113(22):5401–5411.
   PubMed Web of Science ®Google Scholar
• Grunfeld EA, Hunter MS, Sikka P, et al. Adherence beliefs among breast cancer patients taking tamoxifen. Patient Educ Couns. 2005;59(1):97–102.
   PubMed Web of Science ®Google Scholar
• Daouphars M, Ouvry M, Lenain P, et al. Preliminary validation of self-assessment tool to measure imatinib adherence in patients with chronic myeloid leukemia. Pharmacotherapy. 2013;33(2):152–156.
   PubMed Web of Science ®Google Scholar
• Tinari N, Fanizza C, Romero M, et al. Identification of subgroups of early breast cancer patients at high risk of nonadherence to adjuvant hormone therapy: results of an Italian survey. Clin Breast Cancer. 2015;15(2):e131–137.
   PubMed Web of Science ®Google Scholar
• Saratsiotou I, Kordoni M, Bakogiannis C, et al. Treatment adherence of cancer patients to orally administered chemotherapy: insights from a Greek study using a self-reported questionnaire. J Oncol Pharm Pract. 2011;17(4):304–311.
   PubMedGoogle Scholar
• Svarstad BL, Chewning BA, Sleath BL, et al. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37(2):113–124.
   PubMed Web of Science ®Google Scholar
• Mathes T, Pieper D, Antoine SL, et al. Adherence influencing factors in patients taking oral anticancer agents: a systematic review. Cancer Epidemiol. 2014;38(3):214–226.
   PubMed Web of Science ®Google Scholar
• Simon R, Latreille J, Matte C, et al. Adherence to adjuvant endocrine therapy in estrogen receptor-positive breast cancer patients with regular follow-up. Can J Surg. 2014;57(1):26–32.
   PubMed Web of Science ®Google Scholar
• Eliasson L, Clifford S, Barber N, et al. Exploring chronic myeloid leukemia patients’ reasons for not adhering to the oral anticancer drug imatinib as prescribed. Leuk Res. 2011;35(5):626–630.
   PubMed Web of Science ®Google Scholar
• Kirk MC, Hudis CA. Insight into barriers against optimal adherence to oral hormonal therapy in women with breast cancer. Clin Breast Cancer. 2008;8(2):155–161.
   PubMed Web of Science ®Google Scholar
• Chen LC, Chen TC, Huang YB, et al. Disease acceptance and adherence to imatinib in Taiwanese chronic myeloid leukaemia outpatients. Int J Clin Pharm. 2014;36(1):120–127.
   PubMed Web of Science ®Google Scholar
• Petrie KJ, Perry K, Broadbent E, et al. A text message programme designed to modify patients’ illness and treatment beliefs improves self-reported adherence to asthma preventer medication. Br J Health Psychol. 2012;17(1):74–84.
   PubMed Web of Science ®Google Scholar
• Berglund E, Lytsy P, Westerling R. Adherence to and beliefs in lipid-lowering medical treatments: a structural equation modeling approach including the necessity-concern framework. Patient Educ Couns. 2013;91(1):105–112.
   PubMed Web of Science ®Google Scholar
• DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol. 2004;23(2):207–218.
   PubMed Web of Science ®Google Scholar
• Gearing RE, Townsend L, MacKenzie M, et al. Reconceptualizing medication adherence: six phases of dynamic adherence. Harv Rev Psychiatry. 2011;19(4):177–189.
   PubMed Web of Science ®Google Scholar